nivolumab
This drug is selected. Its supporting articles are shown below.
Articles mentioning nivolumab
161 articles · page 7 of 14…ved). The best overall response was SD (RECIST 1.1).Conclusions VAX014 monotherapy is well tolerated with evidence of activity in both…
…d and neck squamous cell carcinoma (HNSCC), IMANs combined with nivolumab induced greater tumor cytotoxicity than CPI alone. Notably, IMA…
… reduction in NK and B cells. When 177Lu-PSMA was combined with pembrolizumab, we saw dynamic changes in non-Treg T cell subsets (CD4+ and CD…
…uded: ipilimumab/nivolumab (8/16), nivolumab/relatlimab (7/16), pembrolizumab (1/16). ctDNA change from baseline to 3–4 weeks was not signifi…
… on Cancer stage IV (8th edition).Results All patients received ipilimumab plus nivolumab. The Eastern Cooperative Oncology Group performa…
…nts received ipilimumab and nivolumab (14/31, 45%), followed by pembrolizumab (9/31, 29%), ipilimumab (4/31, 13%), nivolumab (2/31, 6%) and c…
…ion-level assessment.86 Similarly, 177Lu-DOTATATE combined with nivolumab has shown tolerability and preliminary activity in pulmonary ne…
…licated by cytomegalovirus infection, successfully treated with valganciclovir. A repeat colonoscopy demonstrated complete mucosal healing and…
…ce was among melanoma patients receiving combination therapy of ipilimumab and nivolumab, 19% developed ChILI.Liver injury was not attribu…
… during treatment with PD-1 inhibitors. Eight patients received pembrolizumab (six as monotherapy and two in combination with carboplatin plu…
… trial assessing nivolumab plus ipilimumab versus lenvatinib or sorafenib for unresectable hepatocellular carcinoma in the first-line set…